88IV - Public company info - Sinco Pharmaceuticals Holdings Limited

Input the stock code or the company name

Sinco Pharmaceuticals Holdings Limited, 06833.HK - Cash Flow	2019-12	2018-12	2017-12	2016-12	2015-12	2014-12	2013-12	2012-12
Net Cash Flow from Operating Activities	125,256	256,609	-349,432	-26,059	59,674	67,150	78,436	-907
Net Cash Flow from Return on Investments & Servicing of Finance	-10,566	627	-32,966	-13,180	-6,715	-10,301	-726	18
Interest Received	311	627	641	655	390	1,402	336	18
Interest Paid	-10,877	0	-33,607	-9,187	-7,105	-6,703	-1,062	0
Dividend Received	0	0	0	0	0	-5,000	0	0
Dividend Paid	0	0	0	-4,648	0	0	0	0
Others	0	0	0	0	0	0	0	0
Taxes (Paid) / Refunded	-9,408	-1,344	-9,863	-4,499	-13,868	-15,415	-873	0
Net Cash Flow from Investing Activities	-2,545	-1,630	71,985	-206,206	-53,664	-41,628	-89,821	-9,596
Additions to Fixed Assets	-555	-1,154	-4,425	-12,037	-10,245	-33,447	-50,013	-9,596
Disposal of Fixed Assets	0	0	322	0	0	39	0	0
Increase in Investments	-21,990	-25,218	-6,616	-165,175	-22,000	0	0	0
Decrease in Investments	20,000	25,000	108,081	0	0	0	0	0
Net Cash Flow with Related Parties	0	0	0	0	18,948	0	300	40,400
Others	0	-258	-25,377	-28,994	-40,367	-8,220	-40,108	-40,400
Net Cash Flow before Financing Activities	102,737	254,262	-320,276	-249,944	-14,573	-194	-12,984	-10,485
Net Cash Flow from Financing Activities	41,613	-249,599	243,105	335,756	4,037	26,004	27,309	40,400
New Loans	47,484	334,149	632,537	211,039	258,882	414,695	122,011	0
Loans Repayment	-5,871	-485,162	-520,919	-127,924	-273,793	-377,518	-70,002	0
Fixed Income/Debt Instruments	0	30,559	139,881	0	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	-129,145	0	0	0	0	0	0
Equity Financing	0	0	0	252,641	0	0	0	0
Net Cash Flow with Related Parties	0	0	0	0	18,948	0	300	40,400
Others	0	0	-8,394	0	0	-11,173	-25,000	0
Increase(Decrease) in Cash & Cash Equivalents	144,350	4,663	-77,171	85,812	-10,536	25,810	14,325	29,915
Cash & Cash Equivalents at Beginning of Year	80,343	75,651	154,079	60,206	70,216	44,455	30,069	154
Net Cash Flow due to Change in Exchange Rate/Others	63	29	-1,257	8,061	526	-49	61	0
Cash & Cash Equivalents at End of Year	224,756	80,343	75,651	154,079	60,206	70,216	44,455	30,069
Currency	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	1	1	1	1	1	1

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Sinco Pharmaceuticals Holdings Limited , 06833.HK